What is the biosimilar clinical approach, and how is it changing biosimilar approvals in the EU?
The biosimilar clinical approach—as outlined in the latest
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.